Shorter Versus Standard Antithyroid Drug Therapy in Graves’ Disease with Lower Baseline Thyrotropin Receptor Antibody…
Shorter Versus Standard Antithyroid Drug Therapy in Graves’ Disease with Lower Baseline Thyrotropin Receptor Antibody…
Thyroid® Journal – Editor-in-Chief Call for Applications The ATA seeks applications for the next Editor-in-Chief…
From Clinical Thyroidology® for the Public: Several options to treat Graves’ disease exist, including long…
Major Pharmaceuticals initiated a voluntary recall of its levothyroxine sodium tablets on July 13 after…
Alexandria, VA — The American Thyroid Association® (ATA®) has been reaccredited by the Accreditation Council…
Nearly a decade has passed since the previous ATA guidelines were published in 2017, and…